Скачать или смотреть From 30 Years of Coughing to Relief in Weeks: The Science Behind Digital Cough Therapy

Refractory chronic cough affects up to 100 million people worldwide, yet most patients go years, even decades, without effective treatment.

Behavioral Cough Suppression Therapy (BCST) is the only intervention that addresses the neurological root of chronic cough, but a critical shortage of trained therapists means millions never receive care.

In this conversation, speech-language pathologist Dr. Laurie Slovarp and Hyfe's Chief Product Officer Reid Moorsmith, explore why BCST works, the evidence behind it, and how a digital therapeutic built around BCST could bring effective treatment to patients who currently have nowhere to turn.

Topics covered:

00:00 Introductions
00:33 How Dr. Slovarp got involved in chronic cough
01:36 How cough treatment became part of speech pathology
04:25 How Hyfe started measuring cough in the real world
06:25 What is Behavioral Cough Suppression Therapy (BCST)?
11:08 Cough hypersensitivity across different conditions
14:33 Behavioral medicine and the brain
18:34 The evidence base: remission, efficacy, and what changes
21:45 The psychosocial toll of chronic cough
23:59 Patient story: 30 years of coughing, gone in two weeks
26:47 Why isn't BCST everywhere?
29:12 Building a digital therapeutic for chronic cough
36:19 Regulatory strategy, safety, and pathway to market
41:33 How regulators are thinking about digital therapeutics
44:50 What most people don't know about cough
49:31 Hopes for the next decade

Visit our website for more information:
https://www.hyfe.com/

Follow us on our social media accounts:
LinkedIn -   / hyfe  
Twitter -   / hyfeapp